Annovis Bio (ANVS) Stock Chart & Stock Price History → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free ANVS Stock Alerts $8.31 +0.28 (+3.49%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Annovis Bio Stock Price Performance5 Day Performance0.00%1 Month Performance-17.40%3 Month Performance-20.33%6 Month Performance+36.90%Year-To-Date Performance-55.56%1 Year Performance-38.35% Receive ANVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. ANVS Stock Chart for Sunday, May, 19, 2024 ANVS Chart by TradingView Annovis Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$8.03$8.33+3.74%$8.35$7.38471,908 shs$93.05 million05/16/2024$8.75$8.03-8.23%$9.08$8.03451,681 shs$89.70 million05/15/2024$8.31$8.75+5.29%$10.34$8.491.02 million shs$97.74 million05/14/2024$6.85$8.31+21.31%$8.35$6.95784,350 shs$91.49 million05/13/2024$5.93$6.85+15.51%$7.26$6.17588,395 shs$75.42 million05/10/2024$6.03$6.02-0.17%$6.35$5.40535,763 shs$66.28 million Get the Latest News and Ratings for ANVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$4.80$6.03+25.63%$6.93$5.002.11 million shs$66.39 million05/08/2024$5.30$4.80-9.43%$5.28$4.79419,478 shs$52.85 million05/07/2024$5.39$5.30-1.67%$5.56$5.21328,727 shs$58.35 million05/06/2024$5.18$5.39+4.05%$5.76$5.21395,841 shs$59.34 million05/03/2024$5.48$5.20-5.11%$5.73$4.86609,415 shs$57.25 million05/02/2024$6.11$5.48-10.31%$6.16$5.48672,419 shs$60.34 million05/01/2024$5.52$6.11+10.69%$6.31$5.461.04 million shs$67.28 million04/30/2024$7.29$5.52-24.28%$6.89$5.372.17 million shs$60.78 million04/29/2024$18.01$7.29-59.52%$19.50$5.259.59 million shs$80.26 million04/26/2024$13.60$18.08+32.94%$18.20$13.711.06 million shs$199.06 million04/25/2024$12.76$13.60+6.58%$13.64$12.55329,659 shs$149.74 million04/24/2024$11.91$12.76+7.18%$13.65$11.99489,991 shs$140.49 million04/23/2024$11.49$11.91+3.61%$12.34$11.44226,539 shs$131.07 million04/22/2024$10.06$11.49+14.21%$11.74$10.10319,975 shs$126.51 million04/19/2024$9.88$10.06+1.82%$10.18$9.62224,080 shs$110.76 million04/18/2024$9.07$9.88+8.93%$9.88$9.05240,766 shs$108.78 million04/17/2024$10.01$9.07-9.39%$10.32$8.86291,797 shs$99.87 million04/16/2024$11.11$10.01-9.90%$11.12$9.60192,403 shs$110.21 million04/15/2024$11.63$11.11-4.47%$11.99$10.86153,980 shs$122.32 million04/12/2024$12.20$11.68-4.26%$12.20$11.59132,327 shs$128.60 million04/11/2024$11.74$12.20+3.92%$12.33$11.80144,571 shs$134.32 million04/10/2024$11.49$11.74+2.18%$11.80$10.9597,838 shs$129.26 million04/09/2024$11.57$11.49-0.69%$12.15$11.26141,229 shs$126.51 million04/08/2024$11.10$11.57+4.23%$11.68$10.91157,407 shs$127.39 million04/05/2024$11.07$11.10+0.27%$11.59$10.85185,995 shs$122.21 million04/04/2024$11.22$11.07-1.34%$11.47$10.87183,586 shs$121.88 million04/03/2024$11.14$11.22+0.72%$11.59$11.14118,040 shs$123.53 million04/02/2024$11.99$11.14-7.05%$12.32$11.07200,262 shs$117.86 million04/01/2024$11.90$11.99+0.71%$12.44$11.55191,227 shs$126.80 million03/29/2024$11.86$11.90+0.34%$12.58$11.58249,607 shs$125.90 million03/28/2024$11.95$11.86-0.75%$12.58$11.58249,597 shs$125.48 million03/27/2024$11.90$11.95+0.42%$12.30$11.59173,464 shs$126.43 million03/26/2024$11.90$11.90$12.45$11.53252,614 shs$125.90 million03/25/2024$11.31$11.90+5.22%$11.92$10.92303,972 shs$125.90 millionHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs03/22/2024$11.84$11.31-4.48%$11.81$10.60254,620 shs$119.66 million03/21/2024$11.09$11.84+6.81%$12.45$10.80423,711 shs$125.27 million03/20/2024$9.00$11.09+23.17%$13.26$9.612.14 million shs$117.28 million03/19/2024$9.39$9.00-4.15%$9.44$8.91154,337 shs$95.22 million03/18/2024$9.09$9.39+3.30%$10.05$9.32157,967 shs$99.35 million03/15/2024$8.98$9.11+1.45%$9.37$8.98119,569 shs$96.38 million03/14/2024$9.09$8.98-1.21%$9.20$8.8980,392 shs$95.01 million03/13/2024$9.34$9.09-2.68%$9.62$9.00126,700 shs$98.82 million03/12/2024$9.03$9.34+3.43%$9.45$9.0069,116 shs$98.82 million03/11/2024$8.97$9.03+0.67%$9.12$8.7756,948 shs$95.54 million03/08/2024$8.80$8.97+1.93%$9.25$8.8268,485 shs$94.90 million03/07/2024$9.35$8.80-5.88%$9.42$8.8091,812 shs$93.10 million03/06/2024$9.09$9.35+2.86%$9.39$9.0784,411 shs$98.92 million03/05/2024$9.11$9.09-0.22%$9.35$8.99100,076 shs$96.17 million03/04/2024$8.87$9.11+2.71%$9.45$8.82100,638 shs$96.38 million03/01/2024$8.47$8.87+4.72%$9.45$8.46186,840 shs$93.85 million02/29/2024$8.89$8.47-4.67%$8.99$8.10290,710 shs$89.61 million02/28/2024$9.78$8.89-9.15%$9.33$8.64328,342 shs$94.00 million02/27/2024$8.87$9.78+10.26%$9.88$8.70266,758 shs$103.47 million02/26/2024$9.94$8.87-10.76%$9.94$8.59476,865 shs$93.85 million02/23/2024$10.33$9.97-3.48%$10.33$9.55326,050 shs$105.48 million02/22/2024$10.18$10.33+1.47%$10.48$9.9784,822 shs$109.29 million02/21/2024$10.07$10.18+1.09%$10.38$9.9695,511 shs$107.70 million02/20/2024$10.43$10.07-3.45%$10.66$9.94125,983 shs$106.54 million02/19/2024$10.43$10.43$11.46$10.25214,900 shs$110.35 million Related Companies: Immix Biopharma Stock Chart Reneo Pharmaceuticals Stock Chart Celularity Stock Chart CalciMedica Stock Chart AEON Biopharma Stock Chart Checkpoint Therapeutics Stock Chart Eledon Pharmaceuticals Stock Chart Kezar Life Sciences Stock Chart Eagle Pharmaceuticals Stock Chart BioLineRx Stock Chart Receive ANVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ANVS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetry[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsNext President (Not Trump. Not Biden.)The Freeport Society41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annovis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.